BCL2 and neoplasm: In multiple tumour contexts, low SHBG states are associated with increased c-Myc and Bcl-2 expression and activity, upregulation of glycolytic effectors GLUT1, LDH and HK2, promoting mitochondrial resistance to apoptosis.